Mycobacterium bovis Bacille Calmette-Guérin as a Vaccine Vector for Global Infectious Disease Control
Tuberculosis Research and Treatment · 2011
DOI: 10.1155/2011/574591 ↗At a glance
Journal article in Tuberculosis Research and Treatment, 2011. Written by Kazuhiro Matsuo and 1 co-authors. Institution: R & D Department, Japan BCG Laboratory, 3-1-5 Matsuyama, Kiyose, Tokyo 204-0022, Japan. Cited 10 times so far (Crossref); 70 references. The full text is freely available (open access, CC BY 3.0).
Abstract (original language)
Mycobacterium bovis bacille Calmette-Guérin (BCG) is the only available vaccine for tuberculosis (TB). Although this vaccine is effective in controlling infantile TB, BCG-induced protective effects against pulmonary diseases in adults have not been clearly demonstrated. Recombinant BCG (rBCG) technology has been extensively applied to obtain more potent immunogenicity of this vaccine, and several candidate TB vaccines have currently reached human clinical trials. On the other hand, recent progress in the improvement of the BCG vector, such as the codon optimization strategy and combination with viral vector boost, allows us to utilize this bacterium in HIV vaccine development. In this paper, we review recent progress in rBCG-based vaccine studies that may have implications in the development of novel vaccines for controlling global infectious diseases in the near future.
Authors and institutions
- R & D Department, Japan BCG Laboratory, 3-1-5 Matsuyama, Kiyose, Tokyo 204-0022, Japan.
Cite
APA
Matsuo, K., & Yasutomi, Y. (2011). Mycobacterium bovis Bacille Calmette-Guérin as a Vaccine Vector for Global Infectious Disease Control. Tuberculosis Research and Treatment. https://doi.org/10.1155/2011/574591
Vancouver
Matsuo K, Yasutomi Y. Mycobacterium bovis Bacille Calmette-Guérin as a Vaccine Vector for Global Infectious Disease Control. Tuberculosis Research and Treatment. 2011. doi:10.1155/2011/574591
BibTeX
@article{Matsuo2011,
author = {Matsuo, Kazuhiro and Yasutomi, Yasuhiro},
title = {Mycobacterium bovis Bacille Calmette-Guérin as a Vaccine Vector for Global Infectious Disease Control},
journal = {Tuberculosis Research and Treatment},
year = {2011},
doi = {10.1155/2011/574591}
}
EUVIMED